Mangoceuticals (MGRX) Assets Average (2023 - 2026)

Mangoceuticals (MGRX) has 4 years of Assets Average data on file, last reported at $15.3 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 17.74% year-over-year to $15.3 million; the trailing twelve-month figure through Mar 2026 stood at $15.3 million (down 17.74% YoY), and the FY2025 full-year result was $15.7 million, up 91.58% from the prior year.
• Assets Average slipped to $15.3 million in Q1 2026, from $16.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $21.3 million in Q2 2025 to a low of $676120.0 in Q1 2024.
• A 4-year average of $10.7 million and a median of $15.0 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average plunged 73.58% in 2024 and soared 2645.4% in 2025, its largest moves.
• Tracing MGRX's Assets Average over 4 years: stood at $1.3 million in 2023, then surged by 1039.8% to $15.1 million in 2024, then gained by 8.15% to $16.3 million in 2025, then decreased by 6.38% to $15.3 million in 2026.
• Business Quant data shows MGRX's Assets Average at $15.3 million in Q1 2026, $16.3 million in Q4 2025, and $18.7 million in Q3 2025.